# FDA Inspection 895060 - UF Reproductive Medicine at Springhill - September 11, 2014

Source: https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/611644c6-cfe3-492f-852b-b1a04b765f16
Source feed: FDA_Inspections

> FDA Inspection 895060 for UF Reproductive Medicine at Springhill on September 11, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 895060
- Company Name: UF Reproductive Medicine at Springhill
- Inspection Date: 2014-09-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1303158 - 2026-02-09](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/f3dbb3ff-f8b0-4fc2-9bb7-8db5fa1a8b3f)
- [FDA Inspection 1303158 - 2026-02-09](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/29502ffa-6aa7-424f-a21c-bcd58dd22ec6)
- [FDA Inspection 1191870 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/41ff8722-cb72-4fb9-b1dd-b9b36b954a25)
- [FDA Inspection 1191870 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/04541086-ae3f-430b-9b6c-9f79952dfd8e)
- [FDA Inspection 1191870 - 2022-11-07](https://www.keypedia.com/records/fda_inspections/uf-reproductive-medicine-at-springhill/c74c1bb0-239c-4d4a-84c6-35494d460673)

Company: https://www.keypedia.com/companies/uf-reproductive-medicine-at-springhill/c5a462e7-cc93-4ddc-a8a8-b0ef73ca28e0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d